Disclaimer
The Bar Council of India does not permit advertisement or solicitation by advocates in any form or manner. By accessing this website, www.khaitanco.com, you acknowledge and confirm that you are seeking information relating to Khaitan & Co of your own accord and that there has been no form of solicitation, advertisement or inducement by Khaitan & Co or its members. The content of this website is for informational purposes only and should not be interpreted as soliciting or advertisement. No material/information provided on this website should be construed as legal advice. Khaitan & Co shall not be liable for consequences of any action taken by relying on the material/information provided on this website. The contents of this website are the intellectual property of Khaitan & Co.
Khaitan & Co advised Kotak Life Sciences Fund I and Alkemi Venture Fund II Scheme I in their primary investment in Zeroharm Sciences Pvt Ltd, a nutraceutical company.
The core team consisted of Sanchit Agarwal (Partner), Pulkit Chaturvedi (Principal Associate), Aditi Gupta (Senior Associate), Jubin Jay (Senior Associate), Daryl Menezes (Associate), Shriya Garg (Associate), and Sameer Parihar (Associate).
Back
